Violation Detail
Standard Cited: 19101030 F01 IID Bloodborne pathogens.
Inspection Nr: 314506338
Citation: 02003A
Citation Type: Other
Abatement Status: I
Initial Penalty:
Current Penalty:
Issuance Date: 01/05/2011
Nr Instances: 1
Nr Exposed: 120
Abatement Date: 01/10/2011
Gravity: 01
Report ID: 0855610
Contest Date:
Final Order:
Related Event Code (REC):
Emphasis:
Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
---|---|---|---|---|---|---|
Penalty | I: Informal Settlement | 02/23/2011 | 01/10/2011 | Other | ||
Penalty | Z: Issued | 01/05/2011 | 01/10/2011 | Other |
Text For Citation: 02 Item/Group: 003A Hazard: REFINERY
1910.1030(f)(1)(ii)(D)* The employer shall ensure that all medical evaluations and procedures including the hepatitis B vaccine and vaccination series and post-exposure evaluation and follow-up, including prophylaxis, are: Provided according to recommendations of the U.S. Public Health Service current at the time these evaluations and procedures take place, except as specified by this paragraph (f): One employee had not completed his Hepatitis B series and tracking had failed to ensure completion of the series. Ancillary reference: The U.S. Public Health Service (USPHS) provides for some flexibility in scheduling. If the series is interrupted after the first dose, the second dose must be administered as soon as possible, and the second and third doses must be separated by an interval of at least 8 weeks. If only the third dose has been delayed, it must be administered as soon as possible. This permits a certain flexibility, and there should be little or no added financial burden on a reasonably diligent employer if an employee misses a date for a shot. The employer would simply reschedule the missed shot as soon as possible. You must also have your employee tested for antibody to Hepatitis B surface antigen, one to two months after the completion of the three-dose vaccination series. Post-vaccination testing must be completed 1-2 months after the third vaccine dose for results to be meaningful. A protective antibody response is an anti-HBs concentration of 10 or more milliInternational Units per milliliter (?10mIU/mL). Employees who do not respond to the primary vaccination series must be revaccinated with a second three-dose vaccine series and retested, unless they are HbsAg-positive (infected).